云顶新耀与海森生物签署商业化服务协议及授权许可协议 推动商业化协同与多领域布局
Dec 12, 2025 14:35 HKT |  |
|
雲頂新耀與海森生物簽署商業化服務協議及授權許可協議 推動商業化協同與多領域佈局
Dec 12, 2025 14:35 HKT | |
|
Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten
Dec 12, 2025 14:35 HKT | |
|
康哲藥業（0867）抗急性缺血性卒中創新藥注射用Y-3中國NDA獲受理
Dec 11, 2025 20:01 HKT |  |
|
CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China
Dec 11, 2025 20:00 HKT | |
|
康哲药业（0867）抗急性缺血性卒中创新药注射用Y-3中国NDA获受理
Dec 11, 2025 19:53 HKT | |
|
拨康视云股价飙升逾8成 多重利好催化迎价值重估
Dec 11, 2025 08:20 HKT | |
|
Cloudbreak Pharma Soars 80%+ on Multiple Catalysts, Driving Value Re-Rating
Dec 11, 2025 08:20 HKT | |
|
撥康視雲股價飆升逾8成 多重利好催化迎價值重估
Dec 11, 2025 08:20 HKT | |
|
Immortal Dragons Backs Etheros Pharmaceuticals: Targeting Aging-Related Disease with Breakthrough Catalytic Antioxidants
Dec 05, 2025 15:00 HKT |  |
|
君聖泰醫藥公佈HTD1801與達格列淨的頭對頭III期臨床研究結果 展現控糖優勢及心血管代謝優效獲益
Dec 02, 2025 10:59 HKT |  |
|
君圣泰医药公布HTD1801与达格列净的头对头III期临床研究结果 展现控糖优势及心血管代谢优效获益
Dec 02, 2025 10:16 HKT | |
|
OBI-902 has been granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma
Nov 17, 2025 20:00 HKT |  |
|
Bright China 2025: Airdoc PBM Vision Rehabilitation Device Clinical Research Data Release
Nov 11, 2025 09:22 HKT |  |
|
Bright China 2025：鷹瞳PBM視力康復儀臨牀研究數據發佈
Nov 11, 2025 09:20 HKT | |
|
Bright China 2025：鹰瞳PBM视力康复仪临床研究数据发布
Nov 11, 2025 09:20 HKT | |
|
全球首創抗炎代謝調節劑HTD1801完成2型糖尿病III期臨床研究 展現持續52周的綜合獲益與安全性優勢
Oct 31, 2025 08:30 HKT | |
|
???????????HTD1801??2????III????? ????52????????????
Oct 31, 2025 08:30 HKT | |
|
CMS (867.HK; 8A8.SG) NDA for AD Indication of Long-acting Anti-IL-4Ra Humanized Monoclonal Antibody Injection MG-K10 Accepted in China
Oct 30, 2025 20:00 HKT | |
|
康哲药业（867.HK;8A8.SG）长效抗IL-4Rα人源化单抗注射液MG-K10特应性皮炎适应症中国NDA已获受理
Oct 30, 2025 18:27 HKT | |
|